AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32660329 — intervention group
Group type: EXPERIMENTAL
Intervention: FCR trial
Number of subjects: 0
Study 32660329 — intervention group
Group type: EXPERIMENTAL
Intervention: RD
Number of subjects: 0
Study 34391923 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (ES)
Number of subjects: 370
Study 34391923 — intervention group
Group type: COMPARATOR
Intervention: Non-endoscopic sphincterotomy (non-ES)
Number of subjects: 370
Study 34772398 — intervention group
Group type: EXPERIMENTAL
Intervention: AH Plus sealer
Number of subjects: 40
Study 34772398 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver nanoparticle-modified AH Plus sealer
Number of subjects: 40
Study 34772398 — intervention group
Group type: COMPARATOR
Intervention: Negative control (filled without sealer)
Number of subjects: 40
Study 34772398 — intervention group
Group type: COMPARATOR
Intervention: Positive control (filled without sealer)
Number of subjects: 40
Study 33216667 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop control (CLC) insulin delivery system
Number of subjects: 63
Study 33216667 — intervention group
Group type: COMPARATOR
Intervention: Sensor augmented pump (SAP)
Number of subjects: 63
Study 33378487 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP) performed every activation (experimental group; EG)
Number of subjects: 24
Study 33378487 — intervention group
Group type: COMPARATOR
Intervention: Conventional sliding mechanics (control group; CG)
Number of subjects: 24
Study 35334629 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) rehabilitation program
Number of subjects: 75
Study 32746137 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyramid Non‐local UNet (PN‐UNet) for landmark detection
Number of subjects: 10000
Study 37552643 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent early childhood development intervention
Number of subjects: 0
Study 37552643 — intervention group
Group type: COMPARATOR
Intervention: Local standard of care (control)
Number of subjects: 0
Study 34444627 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflective practice journal
Number of subjects: 0
Study 33022483 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Body Image (HBI) intervention
Number of subjects: 2446
Study 33022483 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 2446
Study 35790509 — intervention group
Group type: EXPERIMENTAL
Intervention: Stomatognathic system functional exercise (SSFE)
Number of subjects: 60
Study 35790509 — intervention group
Group type: COMPARATOR
Intervention: Maxillary full dentition occlusal splint
Number of subjects: 60
Study 34460140 — intervention group
Group type: EXPERIMENTAL
Intervention: Approach Bias Modification (ABM) with real tDCS
Number of subjects: 15
Study 34460140 — intervention group
Group type: COMPARATOR
Intervention: Approach Bias Modification (ABM) with sham tDCS
Number of subjects: 15
Study 35060542 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (FA) tablets 0.8 mg and oral levamlodipine besylate 2.5 mg, once a day for 12 weeks, followed by adjusted FA dose for another 12 weeks
Number of subjects: 126
Study 35060542 — intervention group
Group type: COMPARATOR
Intervention: Oral levamlodipine besylate tablets 2.5 mg and placebo, once a day
Number of subjects: 126
Study 33144358 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory organisational workplace intervention
Number of subjects: 3012
Study 33377285 — intervention group
Group type: EXPERIMENTAL
Intervention: MP-gel applied as SCT (short contact therapy) once daily (evening application) with complete removal after 1 hour using a gentle cleanser
Number of subjects: 46
Study 33377285 — intervention group
Group type: COMPARATOR
Intervention: MP-gel used as SAT (standard application therapy) once daily (evening application)
Number of subjects: 46
Study 33871486 — intervention group
Group type: EXPERIMENTAL
Intervention: Light curing 120 seconds after cement injection (SG3)
Number of subjects: 48
Study 33871486 — intervention group
Group type: COMPARATOR
Intervention: No light curing (SG1)
Number of subjects: 48
Study 33871486 — intervention group
Group type: COMPARATOR
Intervention: Light curing 20 seconds after cement injection (SG2)
Number of subjects: 48
Study 32826768 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-flap Mattress Suture with Deep Sclerectomy
Number of subjects: 20
Study 32826768 — intervention group
Group type: COMPARATOR
Intervention: Standard Surgery
Number of subjects: 20
Study 34467450 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini Hyrax
Number of subjects: 34
Study 34467450 — intervention group
Group type: COMPARATOR
Intervention: Hyrax
Number of subjects: 34
Study 33413744 — intervention group
Group type: EXPERIMENTAL
Intervention: TQLB with 0.6 ml/kg of 0.5% ropivacaine plus general anesthesia
Number of subjects: 60
Study 33413744 — intervention group
Group type: COMPARATOR
Intervention: Control group (general anesthesia alone)
Number of subjects: 60
Study 33413744 — intervention group
Group type: EXPERIMENTAL
Intervention: TQLB group
Number of subjects: 60
Study 33413744 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 36060955 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once or two times daily) with metformin
Number of subjects: 120
Study 36060955 — intervention group
Group type: COMPARATOR
Intervention: Vildagliptin (50 mg once or two times daily) with metformin
Number of subjects: 120
Study 34465265 — intervention group
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin (belamaf)
Number of subjects: 0
Study 34465265 — intervention group
Group type: COMPARATOR
Intervention: Selinexor plus dexamethasone (SEL+DEX)
Number of subjects: 0
Study 36462038 — intervention group
Group type: EXPERIMENTAL
Intervention: NP + TE (nanofilled composite and 2-step total-etch adhesive system)
Number of subjects: 80
Study 36462038 — intervention group
Group type: EXPERIMENTAL
Intervention: NP + UA (nanofilled composite and universal adhesive system)
Number of subjects: 80
Study 36462038 — intervention group
Group type: EXPERIMENTAL
Intervention: MH + TE (microhybrid composite and 2-step total-etch adhesive)
Number of subjects: 80
Study 36462038 — intervention group
Group type: EXPERIMENTAL
Intervention: MH + UA (microhybrid composite and universal adhesive)
Number of subjects: 80
Study 36462038 — intervention group
Group type: EXPERIMENTAL
Intervention: MH + TE
Number of subjects: 80
Study 36462038 — intervention group
Group type: EXPERIMENTAL
Intervention: NP + TE
Number of subjects: 80
Study 36462038 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study 33611640 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee arthroscopy
Number of subjects: 50
Study 32721919 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP) 0.3 ug/kg, administered 30 min once a day after surgery
Number of subjects: 59
Study 32721919 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline 50 ml for 30 min)
Number of subjects: 59
Study 32721919 — intervention group
Group type: EXPERIMENTAL
Intervention: Desmopressin acetate (DDAVP)
Number of subjects: 59
Study 32721919 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 59
Study 34981449 — intervention group
Group type: EXPERIMENTAL
Intervention: Islamic-based intervention
Number of subjects: 62
Study 34981449 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 62
Study 32419114 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial treatments emphasizing learning skills and strategies (82.5% preference among parents)
Number of subjects: 127
Study 32419114 — intervention group
Group type: EXPERIMENTAL
Intervention: Involvement of parents in treatment (96.8% preference among parents)
Number of subjects: 127
Study 32419114 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist meeting mostly with youth alone (67.2% preference among youth)
Number of subjects: 127
Study 32419114 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing information with parents (78.1% preference among youth)
Number of subjects: 127
Study 32419114 — intervention group
Group type: EXPERIMENTAL
Intervention: Response of 'don't know' to preferred therapeutic approach (43.8% among youth)
Number of subjects: 127
Study 36111906 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (6 mg)
Number of subjects: 8
Study 36111906 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 32632880 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver-directed surgical approaches and locally ablative procedures
Number of subjects: 0
Study 32632880 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic liver-directed techniques (transarterial embolization, chemoembolization, radioembolization)
Number of subjects: 0
Study 32632880 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide receptor radionuclide therapy
Number of subjects: 0
Study 32632880 — intervention group
Group type: EXPERIMENTAL
Intervention: Various systemic medical therapies
Number of subjects: 0
Study 35701830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral naproxen 500 mg twice daily for 10 days
Number of subjects: 0
Study 35701830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32303041 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral group therapy (work‐coping group WG)
Number of subjects: 107
Study 32303041 — intervention group
Group type: COMPARATOR
Intervention: Recreational group (recreational group RG)
Number of subjects: 107
Study 35958676 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical neurolysis
Number of subjects: 10
Study 33459040 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light (BWL) exposure (1260 lux at 20 inches, 440–480 nanometers) for 30 minutes each morning
Number of subjects: 131
Study 33459040 — intervention group
Group type: COMPARATOR
Intervention: Red light exposure (<450 lux, no light between 440 and 480 nanometers) for 30 minutes each morning
Number of subjects: 131
Study 32932234 — intervention group
Group type: EXPERIMENTAL
Intervention: RS-OP
Number of subjects: 12
Study 32932234 — intervention group
Group type: COMPARATOR
Intervention: RS-NO
Number of subjects: 12
Study 32932234 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-NO
Number of subjects: 12
Study 32932234 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-OP
Number of subjects: 12
Study 35820447 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming (2 sets high-load parallel squats with a 20% velocity loss cut-off)
Number of subjects: 14
Study 35820447 — intervention group
Group type: EXPERIMENTAL
Intervention: Priming
Number of subjects: 14
Study 35820447 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 14
Study 33548897 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprepitant (320 mg)
Number of subjects: 0
Study 33548897 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35220062 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic Auditory Stimulation (RAS) during treadmill gait training
Number of subjects: 50
Study 35220062 — intervention group
Group type: COMPARATOR
Intervention: Non-RAS treadmill gait training
Number of subjects: 50
Study 34425320 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy diet supplemented with 30 mL/d of extra virgin olive oil (OOG)
Number of subjects: 149
Study 34425320 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy diet supplemented with 30 g/d of pecans (PNG)
Number of subjects: 149
Study 34425320 — intervention group
Group type: COMPARATOR
Intervention: Healthy diet based on guidelines (control group [CG])
Number of subjects: 149
Study 34477459 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor plus aspirin
Number of subjects: 11016
Study 34477459 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 11016
Study 33296484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique + Nerve Stimulator
Number of subjects: 66
Study 33296484 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique
Number of subjects: 66
Study 33296484 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve stimulator
Number of subjects: 66
Study 33296484 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group (Ultrasound-guided technique + Nerve Stimulator)
Number of subjects: 66
Study 33296484 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 66
Study 35015168 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Anaesthesia (SA)
Number of subjects: 60
Study 35015168 — intervention group
Group type: COMPARATOR
Intervention: Local Anaesthesia (LA)
Number of subjects: 60
Study 34232000 — intervention group
Group type: EXPERIMENTAL
Intervention: PLLA reconstituted with 8 mL sterile water for injection (SWFI) including 1 mL 2% lidocaine
Number of subjects: 80
Study 34232000 — intervention group
Group type: COMPARATOR
Intervention: PLLA reconstituted with 5 mL sterile water for injection (SWFI)
Number of subjects: 80
Study 32933499 — intervention group
Group type: EXPERIMENTAL
Intervention: Sandwich principle lecture
Number of subjects: 64
Study 32933499 — intervention group
Group type: COMPARATOR
Intervention: Classical face-to-face lecture
Number of subjects: 64
Study 35413837 — intervention group
Group type: EXPERIMENTAL
Intervention: High green leafy vegetable dietary intervention
Number of subjects: 20
Study 35413837 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 33121980 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitolisant (titrated individually at up to 20 mg/day for 12 weeks)
Number of subjects: 244
Study 33121980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 33121980 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitolisant
Number of subjects: 244
Study 32224119 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Acupuncture (MA)
Number of subjects: 66
Study 32224119 — intervention group
Group type: COMPARATOR
Intervention: Electrical Acupuncture (EA)
Number of subjects: 66
Study 36335909 — intervention group
Group type: EXPERIMENTAL
Intervention: CDE alongside home‐based chest physiotherapy
Number of subjects: 24
Study 36335909 — intervention group
Group type: COMPARATOR
Intervention: Chest physiotherapy and home‐based walking program
Number of subjects: 24
Study 33367621 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (100 mg daily)
Number of subjects: 19114
Study 33367621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study 32474426 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-specific anticancer drugs
Number of subjects: 433
Study 35503787 — intervention group
Group type: EXPERIMENTAL
Intervention: Super-circuit training (SCT)
Number of subjects: 29
Study 35503787 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity continuous-aerobic training (CAT)
Number of subjects: 29
Study 33671147 — intervention group
Group type: EXPERIMENTAL
Intervention: RS2-enriched wheat rolls
Number of subjects: 0
Study 33671147 — intervention group
Group type: COMPARATOR
Intervention: Conventional wheat rolls
Number of subjects: 0
Study 33778993 — intervention group
Group type: EXPERIMENTAL
Intervention: Body height measurement
Number of subjects: 4046
Study 33778993 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass and BMI measurement
Number of subjects: 4046
Study 33778993 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor abilities tests
Number of subjects: 4046
Study 33778993 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of body mass, BMI, and body height with motor abilities
Number of subjects: 4046
Study 34851251 — intervention group
Group type: EXPERIMENTAL
Intervention: Ularitide as a continuous intravenous infusion during hospitalisation as an add-on to any diuretic treatment
Number of subjects: 0
Study 34851251 — intervention group
Group type: COMPARATOR
Intervention: Placebo as a continuous intravenous infusion during hospitalisation as an add-on to any diuretic treatment
Number of subjects: 0
Study 32270862 — intervention group
Group type: EXPERIMENTAL
Intervention: tesamorelin
Number of subjects: 61
Study 32270862 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 61
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Total fertility rate
Number of subjects: 25144
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude birth rate
Number of subjects: 25144
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Crude death rate
Number of subjects: 25144
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dependency ratio
Number of subjects: 25144
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth rates in urban residents
Number of subjects: 25144
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth rates in women with basic education
Number of subjects: 25144
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of deaths reported
Number of subjects: 25144
Study 33115376 — intervention group
Group type: EXPERIMENTAL
Intervention: Life expectancy
Number of subjects: 25144
Study 36433792 — intervention group
Group type: EXPERIMENTAL
Intervention: Family centered Function‐focused Care (Fam‐FFC)
Number of subjects: 140
Study 36433792 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain
Number of subjects: 140
Study 33910333 — intervention group
Group type: EXPERIMENTAL
Intervention: KCd (Carfilzomib + Cyclophosphamide + Dexamethasone)
Number of subjects: 300
Study 33910333 — intervention group
Group type: COMPARATOR
Intervention: VCd (Bortezomib + Cyclophosphamide + Dexamethasone)
Number of subjects: 300
Study 33910333 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib maintenance
Number of subjects: 300
Study 616741974 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose group (1850 MBq)
Number of subjects: 278
Study 616741974 — intervention group
Group type: COMPARATOR
Intervention: High-dose group (3700 MBq)
Number of subjects: 278
Study 616741974 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 278
Study 36204963 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implantation group (17 implants)
Number of subjects: 30
Study 36204963 — intervention group
Group type: COMPARATOR
Intervention: Delayed implantation group (19 implants)
Number of subjects: 30
Study 34455706 — intervention group
Group type: EXPERIMENTAL
Intervention: edoxaban
Number of subjects: 88
Study 32444149 — intervention group
Group type: EXPERIMENTAL
Intervention: Forefoot strike (FFS)
Number of subjects: 39
Study 32444149 — intervention group
Group type: COMPARATOR
Intervention: Cadence (CAD)
Number of subjects: 39
Study 35730535 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual use of oral tobacco-derived nicotine (OTDN) products (VERVE chews/discs)
Number of subjects: 213
Study 35730535 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive use of discs or chews
Number of subjects: 213
Study 35730535 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual use of discs/chews
Number of subjects: 213
Study 35730535 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive use of discs/chews
Number of subjects: 213
Study 35730535 — intervention group
Group type: COMPARATOR
Intervention: Continue smoking
Number of subjects: 213
Study 33542071 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure targets (<130 mm Hg)
Number of subjects: 5001
Study 33542071 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure targets (≥130 mm Hg)
Number of subjects: 5001
Study 32093709 — intervention group
Group type: EXPERIMENTAL
Intervention: Forum theater sessions (2 sessions)
Number of subjects: 488
Study 32093709 — intervention group
Group type: EXPERIMENTAL
Intervention: Being an actor in forum theater
Number of subjects: 488
Study 34039576 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery catheter
Number of subjects: 70
Study 34039576 — intervention group
Group type: COMPARATOR
Intervention: Stylet
Number of subjects: 70
Study 34233204 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch‐and‐rinse (Variolink N)
Number of subjects: 40
Study 34233204 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐etch (Panavia F2.0)
Number of subjects: 40
Study 34233204 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐adhesive (RelyX Unicem)
Number of subjects: 40
Study 34233204 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 32251026 — intervention group
Group type: EXPERIMENTAL
Intervention: siponimod
Number of subjects: 0
Study 32251026 — intervention group
Group type: EXPERIMENTAL
Intervention: ocrelizumab
Number of subjects: 0
Study 32251026 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-inflammatory drugs
Number of subjects: 0
Study 32251026 — intervention group
Group type: EXPERIMENTAL
Intervention: neuroprotective drugs
Number of subjects: 0
Study 34474131 — intervention group
Group type: EXPERIMENTAL
Intervention: Zenith Alpha™ abdominal stent graft
Number of subjects: 347
Study 32883555 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent GBS vaccine
Number of subjects: 75
Study 32883555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 36323243 — intervention group
Group type: EXPERIMENTAL
Intervention: AM‐301 (bentonite nasal spray)
Number of subjects: 36
Study 36323243 — intervention group
Group type: COMPARATOR
Intervention: HPMC (Nasaleze® Allergy Blocker)
Number of subjects: 36
Study 36323243 — intervention group
Group type: COMPARATOR
Intervention: Comparison of AM‐301 to HPMC
Number of subjects: 36
Study 36323243 — intervention group
Group type: EXPERIMENTAL
Intervention: AM‐301
Number of subjects: 36
Study 36323243 — intervention group
Group type: COMPARATOR
Intervention: HPMC
Number of subjects: 36
Study 36323243 — intervention group
Group type: COMPARATOR
Intervention: AM‐301 and HPMC
Number of subjects: 36
Study 34759146 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose Methotrexate (HD-MTX) continued-maintenance therapy (3.5g/m2)
Number of subjects: 52
Study 34759146 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiotherapy consisting of HD-MTX followed by whole-brain radiotherapy (WBRT)
Number of subjects: 52
Study 32078493 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized autoregulation-based BP targets
Number of subjects: 90
Study 32078493 — intervention group
Group type: COMPARATOR
Intervention: Static systolic BP thresholds (140 mm Hg and 160 mm Hg)
Number of subjects: 90
Study 35274420 — intervention group
Group type: EXPERIMENTAL
Intervention: KCCQ-PLS improvement
Number of subjects: 698